Cite
HARVARD Citation
Murray Brunt, A. et al. (2020). Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. Lancet. 395 (10237), pp. 1613-1626. [Online].